Clik here to view.
Dr. Reddy’s Expands Strategic Collaboration with Amgen in India
Friday, September 16th 2016 at 10:54am UTC HYDERABAD, India–(BUSINESS WIRE)– Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) today announced that it has expanded its strategic...
View ArticleClik here to view.
Pfizer Receives Positive CHMP Opinion For IBRANCE® (palbociclib) In...
Friday, September 16th 2016 at 11:24am UTC NEW YORK–(BUSINESS WIRE)– Pfizer Inc. (NYSE:PFE) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines...
View ArticleClik here to view.
Pfizer Announces Positive Top-Line Results from REFLECTIONS B537-02 Study for...
Friday, September 16th 2016 at 9:24pm UTC Results confirm similar efficacy of PF-06438179 (infliximab-Pfizer) to Remicade® (infliximab), in combination with methotrexate NEW YORK–(BUSINESS WIRE)–...
View ArticleClik here to view.
PIN Pharma to Present a Poster at Second CRI-CIMT-EATI-AACR International...
Monday, September 19th 2016 at 1:00pm UTC NEW YORK–(BUSINESS WIRE)– PIN Pharma, a pre-clinical immunotherapy company focused on modulating the immune system in oncology, today announced the Company...
View ArticleClik here to view.
Bellicum Pharmaceuticals to Present at the Ladenburg Thalmann 2016 Healthcare...
Tuesday, September 20th 2016 at 11:00am UTC HOUSTON–(BUSINESS WIRE)– Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a clinical stage biopharmaceutical company focused on discovering and developing...
View ArticleClik here to view.
Bristol-Myers Squibb Awards First “Golden Tickets” for LabCentral to PanTher,...
Tuesday, September 20th 2016 at 10:59am UTC NEW YORK & CAMBRIDGE, Mass.–(BUSINESS WIRE)– Bristol-Myers Squibb Company (NYSE:BMY) and LabCentral, an innovative, shared laboratory space designed as...
View ArticleClik here to view.
Teva and Regeneron Announce Global Collaboration to Develop and Commercialize...
Tuesday, September 20th 2016 at 11:00am UTC Novel Nerve Growth Factor (NGF) Antibody Has Potential to Address Limitations of Current Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Opioid Therapies...
View ArticleClik here to view.
Pfizer Invites Public To View And Listen To Webcast Of November 1 Conference...
Tuesday, September 20th 2016 at 2:00pm UTC NEW YORK–(BUSINESS WIRE)– Pfizer Inc. invites investors and the general public to view and listen to a webcast of a conference call with investment analysts...
View ArticleClik here to view.
ACADIA Pharmaceuticals to Present at the Ladenburg Thalmann 2016 Healthcare...
Tuesday, September 20th 2016 at 1:00pm UTC SAN DIEGO–(BUSINESS WIRE)– ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of...
View ArticleClik here to view.
Researchers Demonstrate Hyperspectral Imaging for Multiphoton Microscopy
Tuesday, September 20th 2016 at 2:00pm UTC Researchers at Cornell University have discovered an innovation to extend the current capabilities of this technology WASHINGTON–(BUSINESS WIRE)–...
View ArticleClik here to view.
ArQule to Present at The Leerink Partners Rare Disease and Immuno-Oncology...
Wednesday, September 21st 2016 at 11:00am UTC BURLINGTON, Mass.–(BUSINESS WIRE)– ArQule, Inc. (Nasdaq: ARQL) today announced that Paolo Pucci, Chief Executive Officer, and Dr. Brian Schwartz, Chief...
View ArticleClik here to view.
DBV Technologies Receives FDA Fast Track Designation for Viaskin Milk for the...
Wednesday, September 21st 2016 at 5:30am UTC DBV first to announce Fast Track designation for IgE-mediated CMPA; Viaskin Milk is currently being investigated in a Phase IIb study Second Fast Track...
View ArticleClik here to view.
SIGA Announces Bankruptcy Court Approval of Transaction Under Which SIGA Will...
Wednesday, September 21st 2016 at 11:00am UTC NEW YORK–(BUSINESS WIRE)– SIGA Technologies, Inc. (SIGA) (OTCMKTS:SIGA),SIGA Technologies, Inc., a company specializing in the commercialization of...
View ArticleClik here to view.
Unum Therapeutics to Present at the Leerink Partners Roundtable Series: Rare...
Wednesday, September 21st 2016 at 12:00pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Unum Therapeutics, a clinical stage biopharmaceutical company developing a universal cellular immunotherapy to treat...
View ArticleClik here to view.
Kadmon Initiates Placebo-Controlled Phase 2 Clinical Trial Evaluating KD025...
Wednesday, September 21st 2016 at 8:47pm UTC NEW YORK–(BUSINESS WIRE)– Kadmon Holdings, Inc. (NYSE:KDMN) today announced that the first patient has been dosed in a double-blind, placebo-controlled...
View ArticleClik here to view.
Sage Therapeutics to Present at the Leerink Partners Rare Disease Roundtable
Wednesday, September 21st 2016 at 8:05pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat...
View ArticleClik here to view.
Kadmon Initiates Phase 2 Clinical Trial Evaluating KD025 in Chronic...
Wednesday, September 21st 2016 at 8:03pm UTC NEW YORK–(BUSINESS WIRE)– Kadmon Holdings, Inc. (NYSE:KDMN) today announced that the first patient has been dosed in a Phase 2 clinical trial of KD025, the...
View ArticleClik here to view.
Derma Sciences to Present at the Ladenburg Thalmann 2016 Healthcare Conference
Wednesday, September 21st 2016 at 6:02pm UTC PRINCETON, N.J.–(BUSINESS WIRE)– Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, announced today...
View ArticleClik here to view.
Xenetic Biosciences to Present at the Ladenburg Thalmann 2016 Healthcare...
Thursday, September 22nd 2016 at 11:05am UTC – Presentation with a Live Webcast on Tuesday, September 27th at 3:30 p.m. ET – LEXINGTON, Mass.–(BUSINESS WIRE)– Xenetic Biosciences, Inc. (OTCQB: XBIO)...
View ArticleClik here to view.
Early-Cancer Detection Company iCareDx Announces Corporate Name Change To...
Wednesday, September 21st 2016 at 10:03pm UTC NEW YORK–(BUSINESS WIRE)– iCareDx, Inc., a biotechnology company focused on blood-based early detection of cancer, today announced that it has changed its...
View Article